Discover
LTRN
Lantern Pharma Inc.
2.94
1 x 2.36
1 x 2.70
bid
ask
-
0.01
0.34%
15 @ 04:00 PM
2.98 +0.04 (1.36%)
| Ytd | -2.97% | |
| 1y | -27.05% |
2.87
day range
3.05
1.11
52 week range
5.74
| Open | 2.97 | Prev Close | 2.95 | Low | 2.87 | High | 3.05 | Mkt Cap | 37.51M |
| Vol | 126.07K | Avg Vol | 237.85K | EPS | -1.45 | P/E | -2.03 | Forward P/E | -1.50 |
| Beta | 2.30 | Short Ratio | 4.74 | Inst. Own | 24.10% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-12 | 50-d Avg | 3.44 | 200-d Avg | 3.17 | 1yr Est | 20.50 |
| Income Statement | |||
| Operating Expenses | 3.41M | ||
| Research and Development Expense | 1.72M | ||
| Selling, General and Administrative Expense | 1.68M | ||
| Operating Income | -3.41M | ||
| Net Income | -3.33M | ||
| Net Income Common Stock | -3.33M | ||
| Net Income Common Stock (USD) | -3.33M | ||
| Consolidated Income | -3.33M | ||
| Earnings per Basic Share | -0.30 | ||
| Earnings per Basic Share (USD) | -0.30 | ||
| Earnings per Diluted Share | -0.30 | ||
| Earning Before Interest & Taxes (EBIT) | -3.33M | ||
| Earning Before Interest & Taxes (USD) | -3.33M | ||
| Weighted Average Shares | 11.25M | ||
| Weighted Average Shares Diluted | 11.25M | ||
| Balance Sheet | |||
| Cash and Equivalents | 4.92M | ||
| Cash and Equivalents (USD) | 4.92M | ||
| Investments | 1.41M | ||
| Investments Current | 1.41M | ||
| Current Assets | 7.06M | ||
| Property, Plant & Equipment Net | 84.89K | ||
| Total Assets | 7.22M | ||
| Debt Current | 59.08K | ||
| Total Debt | 59.08K | ||
| Current Liabilities | 3.78M | ||
| Total Liabilities | 3.78M | ||
| Accumulated Retained Earnings (Deficit) | -96.47M | ||
| Accumulated Other Comprehensive Income | -35.64K | ||
| Shareholders Equity | 3.45M | ||
| Shareholders Equity (USD) | 3.45M | ||
| Assets Non-Current | 165.81K | ||
| Total Debt (USD) | 59.08K | ||
| Trade and Non-Trade Payables | 3.72M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 22.58K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 494.96K | ||
| Net Cash Flow from Investing | 4.25M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 4.25M | ||
| Net Cash Flow from Operations | -3.77M | ||
| Effect of Exchange Rate Changes on Cash | 17.59K | ||
| Share Based Compensation | 262.92K | ||